101836-20-8

Basic information

• Product Name: Thiocyanic acid, 4-hydroxy-2,3,5-trimethylphenyl ester
• CAS NO: 101836-20-8
• Molecular Formula: C10H11NOS
• Molecular Weight: 193.269
• Mol File: 101836-20-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Thiocyanic acid, 4-hydroxy-2,3,5-trimethylphenyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Thiocyanic acid, 4-hydroxy-2,3,5-trimethylphenyl ester(101836-20-8)
• EPA Substance Registry System: Thiocyanic acid, 4-hydroxy-2,3,5-trimethylphenyl ester(101836-20-8)

Safety Data

• Hazardous Substances Data: 101836-20-8(Hazardous Substances Data)

Upstream product

• 2416-94-6 2,3,6-trimethylphenol 
• 540-72-7 sodium thiocyanide 
• 1147550-11-5 ammonium thiocyanate 

Downstream Products

• 261929-91-3 E_.Z, RS, RS, RS-phytyl-trimethyl-hydroxy-benzenethiol 
• 101836-32-2 2,3,6-Trimethyl-4-((E)-3,7,11,15-tetramethyl-hexadec-1-enylsulfanyl)-phenol 
• 101836-22-0 3-(4-Hydroxy-2,3,5-trimethyl-phenylsulfanyl)-butyric acid methyl ester 
• 101836-23-1 3-(4-hydroxy-2,3,5-trimethyl-phenylsulfanyl)-3-methyl-butyric acid methyl ester 
• 101836-21-9 3-(4-hydroxy-2,3,5-trimethyl-phenylsulfanyl)-propionic acid methyl ester 
• 101836-25-3 3-(4-Hydroxy-2,3,5-trimethyl-phenylsulfanyl)-butyric acid 
• 101836-24-2 3-(4-hydroxy-2,3,5-trimethyl-phenylsulfanyl)-propionic acid 
• 101836-26-4 3-(4-hydroxy-2,3,5-trimethyl-phenylsulfanyl)-3-methyl-butyric acid 
• 101836-34-4 S-(3,3-dimethylallyl)-2,3,5-trimethyl-4-hydroxybenzenethiol 
• 85460-73-7 2,3,5-trimethyl-4-hydroxy-benzenethiol 

Relevant articles and documents

Spiro derivatives as lipoxygenase inhibitors

The present invention is concerned with certain novel spiro substituted heterocylic ring derivatives. These compounds may be useful in the manufacture of pharmaceutical compositions for treating disorders mediated by lipoxygenases. They may also be useful

Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof

The present invention provides an antiproliferative compound having a structural formula where X and Y independently are oxygen, nitrogen o r sulfur; R1 is alkyl, alkenyl, alkynyl, aryl, heteroaryl, carboxylic acid, carboxylate, carboxamide, ester, thioamide, thiolacid, thiolester, saccharide, alkoxy-linked saccharide, amine, sulfonate, sulfate, phosphate, alcohol, ethers or nitriles; R2 and R3 are hydrogen or R4; R4 is methyl, benzyl carboxylic acid, benzyl carboxylate, benzyl carboxamide, benzylester, saccharide or amine; and R5 is alkenyl; where when Y is nitrogen, said nitrogen is substituted with R6, wherein R6 is hydrogen or methyl. Also provided are methods for treating a cell proliferative disease and for inducing apoptosis in a cell comprising administering this compound is also provided.